MD Anderson Cancer Center - Unit 429 — Houston, Texas

MD Anderson Cancer Center - Unit 429 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center - Unit 429 has participated in 1 clinical trials.

Therapeutic areas: Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center - Unit 429?

MD Anderson Cancer Center - Unit 429 has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center - Unit 429 conducted?

MD Anderson Cancer Center - Unit 429 has 1 clinical trials on record. Their work covers Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer.

Is MD Anderson Cancer Center - Unit 429 accredited by Crixeo Health?

MD Anderson Cancer Center - Unit 429 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center - Unit 429?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.